Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831090 · ClinicalTrials.gov registry record
Endothelial Function and Vein Graft Remodeling
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 55
- Enrollment target
NCT00831090 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 55 participants.
The verdict
NCT00831090 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand why some vein bypass grafts develop narrowing. Evidence suggests that there is a relationship between inflammatory markers in the blood and the narrowing that occurs in blood vessels. In this study, we will look at inflammatory markers in the blood and how well the vein graft functions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-01-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00831090
The ClinicalTrials.gov registry entry for NCT00831090 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00831090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00831090 about?
NCT00831090 is a clinical study titled "Endothelial Function and Vein Graft Remodeling". The purpose of this study is to better understand why some vein bypass grafts develop narrowing. Evidence suggests that there is a relationship between inflammatory markers in the blood and the narrowing that occurs in blood vessels. In this study, we will look at inflammatory markers in the blood a...
What is the current status of trial NCT00831090?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2009-01. Estimated completion is 2015-01-16.
Who is sponsoring clinical trial NCT00831090?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.